Free Trial

Henry Schein, Inc. (NASDAQ:HSIC) Shares Purchased by Snyder Capital Management L P

Henry Schein logo with Medical background

Snyder Capital Management L P grew its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 6.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,194,802 shares of the company's stock after acquiring an additional 69,835 shares during the quarter. Henry Schein accounts for about 1.7% of Snyder Capital Management L P's holdings, making the stock its 21st largest position. Snyder Capital Management L P owned 0.96% of Henry Schein worth $82,680,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of HSIC. Lyrical Asset Management LP bought a new stake in shares of Henry Schein in the 4th quarter valued at approximately $126,655,000. Norges Bank bought a new position in shares of Henry Schein during the fourth quarter valued at $103,301,000. National Bank of Canada FI boosted its stake in shares of Henry Schein by 102.4% in the 4th quarter. National Bank of Canada FI now owns 1,084,511 shares of the company's stock valued at $75,048,000 after purchasing an additional 548,561 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in shares of Henry Schein during the 4th quarter worth about $34,720,000. Finally, Clarkston Capital Partners LLC lifted its holdings in Henry Schein by 24.8% during the 4th quarter. Clarkston Capital Partners LLC now owns 1,744,225 shares of the company's stock valued at $120,700,000 after purchasing an additional 346,420 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company's stock.

Insider Buying and Selling

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the transaction, the director now owns 24,805 shares of the company's stock, valued at $1,762,147.20. This represents a 9.50 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the transaction, the chief executive officer now owns 62,688 shares of the company's stock, valued at $4,460,251.20. This represents a 6.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

HSIC has been the topic of a number of recent analyst reports. Jefferies Financial Group boosted their price objective on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research note on Thursday, January 23rd. StockNews.com downgraded shares of Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. UBS Group lowered their price target on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a report on Wednesday, February 26th. Wells Fargo & Company started coverage on Henry Schein in a research report on Friday, February 14th. They issued an "equal weight" rating and a $80.00 price objective on the stock. Finally, Barrington Research reaffirmed an "outperform" rating and set a $90.00 price target on shares of Henry Schein in a research note on Wednesday, February 26th. Six investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $81.10.

View Our Latest Analysis on Henry Schein

Henry Schein Price Performance

NASDAQ:HSIC traded down $1.06 during trading hours on Friday, hitting $65.17. 736,945 shares of the company's stock traded hands, compared to its average volume of 1,623,471. The firm has a market cap of $7.98 billion, a P/E ratio of 26.82, a P/E/G ratio of 2.13 and a beta of 0.84. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The business's fifty day simple moving average is $69.21 and its two-hundred day simple moving average is $71.80. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.19 billion during the quarter, compared to analysts' expectations of $3.25 billion. During the same period in the previous year, the firm earned $0.66 earnings per share. The firm's quarterly revenue was up 5.8% compared to the same quarter last year. On average, research analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

About Henry Schein

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Further Reading

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Should You Invest $1,000 in Henry Schein Right Now?

Before you consider Henry Schein, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.

While Henry Schein currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Free Today: Your Guide to Smarter Options Trades Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Make Your Money Work Harder: The Power of Dividend Investing
7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines